Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;26:199-207

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamaguchi, A.
Right arrow Articles by Iwao, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamaguchi, A.
Right arrow Articles by Iwao, H.

(Hypertension. 1995;26:199-207.)
© 1995 American Heart Association, Inc.


Articles

Transforming Growth Factor-ß1 Expression and Phenotypic Modulation in the Kidney of Hypertensive Rats

Akinori Hamaguchi; Shokei Kim; Kensuke Ohta; Keiko Yagi; Tokihito Yukimura; Katsuyuki Miura; Taneo Fukuda; Hiroshi Iwao

From the Department of Pharmacology, Osaka City University Medical School, and the Department of Drug Safety Research (T.F.), Eisai Co, Ltd, Gifu, Japan.

Correspondence to Shokei Kim, MD, Department of Pharmacology, Osaka City University Medical School, 1-4-54 Asahimachi, Abeno, Osaka 545, Japan.

Abstract We have previously reported that renal mRNA levels for transforming growth factor-ß1, fibronectin, and collagens were increased in 32-week-old stroke-prone spontaneously hypertensive rats (SHRSP) with severe nephrosclerosis. To elucidate the mechanism of hypertension-induced nephrosclerosis, we examined gene expression and localization of transforming growth factor-ß1 and cellular phenotype in the kidney of 25-week-old SHRSP with moderate renal damage. Renal mRNA was measured by Northern blot analysis. The localization of transforming growth factor-ß1 and cellular phenotype was determined by immunohistochemistry. In the kidney of 25-week-old SHRSP, renal transforming growth factor-ß1 mRNA was elevated compared with Wistar-Kyoto rats (WKY), whereas renal collagen mRNAs of SHRSP were not increased. Immunoreactive transforming growth factor-ß1 in SHRSP was mainly localized in glomerular cells. Furthermore, {alpha}-smooth muscle actin and desmin were significantly expressed in SHRSP glomerular cells, in contrast to negligible expression of these proteins in WKY. {alpha}-Smooth muscle actin staining was also observed in interstitial cells, and vimentin, another phenotypic marker, was expressed in atrophic tubular cells of SHRSP, despite no staining of these proteins in WKY. Furthermore, all these phenotypic changes in SHRSP were associated with increased cell proliferation, as shown by the increased number of proliferating cell nuclear antigen–positive cells. Treatment of SHRSP with cilazapril and nifedipine (from the age of 13 to 25 weeks) prevented the increase in transforming growth factor-ß1 expression and the cellular phenotypic modulation and was accompanied by a reduction of urinary albumin excretion and inhibition of cell proliferation. These results indicated that sustained hypertension causes the increased glomerular transforming growth factor-ß1 expression and cellular phenotypic modulation, which may play an important role in the progression of glomerulosclerosis and tubulointerstitial fibrosis in hypertension.


Key Words: transforming growth factor-ß • phenotype • hypertension, genetic • nephrosclerosis • antihypertensive agents




This article has been cited by other articles:


Home page
StrokeHome page
S. Kim-Mitsuyama, E. Yamamoto, T. Tanaka, Y. Zhan, Y. Izumi, Y. Izumiya, T. Ioroi, H. Wanibuchi, and H. Iwao
Critical Role of Angiotensin II in Excess Salt-Induced Brain Oxidative Stress of Stroke-Prone Spontaneously Hypertensive Rats
Stroke, May 1, 2005; 36(5): 1077 - 1082.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Suganami, K. Mori, I. Tanaka, M. Mukoyama, A. Sugawara, H. Makino, S. Muro, K. Yahata, S. Ohuchida, T. Maruyama, et al.
Role of Prostaglandin E Receptor EP1 Subtype in the Development of Renal Injury in Genetically Hypertensive Rats
Hypertension, December 1, 2003; 42(6): 1183 - 1190.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. Miyazaki, I. Aoyama, M. Ise, H. Seo, and T. Niwa
An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-{beta}1 in uraemic rat kidneys
Nephrol. Dial. Transplant., November 1, 2000; 15(11): 1773 - 1781.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Mizushige, L. Yao, T. Noma, H. Kiyomoto, Y. Yu, N. Hosomi, K. Ohmori, and H. Matsuo
Alteration in Left Ventricular Diastolic Filling and Accumulation of Myocardial Collagen at Insulin-Resistant Prediabetic Stage of a Type II Diabetic Rat Model
Circulation, February 29, 2000; 101(8): 899 - 907.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Bohlender, A. Fukamizu, A. Lippoldt, T. Nomura, R. Dietz, J. Menard, K. Murakami, F. C. Luft, and D. Ganten
High Human Renin Hypertension in Transgenic Rats
Hypertension, January 1, 1997; 29(1): 428 - 434.
[Abstract] [Full Text] [PDF]